Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?
Patil V, Noronha V, Joshi A, Muddu Krishna V, Juvekar S, Pantvaidya G, Chaturvedi P, Chaukar D, Arya S, Patil A, Bhosale B, Dongre A, Dcruz AK, Prabhash K. Patil V, et al. Among authors: juvekar s. ISRN Oncol. 2013 Sep 11;2013:259154. doi: 10.1155/2013/259154. eCollection 2013. ISRN Oncol. 2013. PMID: 24109521 Free PMC article.
Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.
Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Arya S, Juvekar S, Pai P, Chatturvedi P, Devendra AC, Ghosh S, D'cruz A, Kumar P. Patil VM, et al. Among authors: juvekar s. Indian J Cancer. 2014 Jan-Mar;51(1):20-4. doi: 10.4103/0019-509X.134608. Indian J Cancer. 2014. PMID: 24947091 Free article.
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.
Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Bhosale B, Arya S, Juvekar S, Banavali S, D'Cruz A, Bhattacharjee A, Prabhash K. Patil VM, et al. Among authors: juvekar s. Oral Oncol. 2015 Mar;51(3):279-86. doi: 10.1016/j.oraloncology.2014.12.002. Epub 2015 Jan 8. Oral Oncol. 2015. PMID: 25578869 Clinical Trial.
Technically unresectable recurrent oral cancers: Is NACT the answer?
Patil VM, Joshi A, Noronha V, Karpe A, Ramaswamy A, Dhumal S, Juvekar S, Arya S, Mahajan A, Chaturvedi P, Pai P, D'Cruz A, Prabhash K. Patil VM, et al. Among authors: juvekar s. Oral Oncol. 2016 May;56:e12-4. doi: 10.1016/j.oraloncology.2016.03.015. Epub 2016 Mar 31. Oral Oncol. 2016. PMID: 27050928 No abstract available.
Neoadjuvant chemotherapy in geriatric head and neck cancers.
Patil VM, Noronha V, Joshi A, Ramaswamy A, Dhumal S, Juvekar S, Arya S, Mahajan A, Chaturvedi P, D'Cruz A, Bhattacharjee A, Prabhash K. Patil VM, et al. Among authors: juvekar s. Head Neck. 2017 May;39(5):886-892. doi: 10.1002/hed.24694. Epub 2017 Mar 1. Head Neck. 2017. PMID: 28248432
204 results